EXCIVA GmbH
Anton Bespalov is a highly experienced individual who holds various roles in the biotech and pharmaceutical industry. Currently serving as the Co-Founder, CSO, and Managing Director at EXCIVA GmbH, a biotech company focusing on developing personalized therapies for neuropsychiatric disorders. Bespalov is also a Co-Founder and Managing Partner at PAASP GmbH, which focuses on the assessment and accreditation of scientific practices. With a background as a Professor at Pavlov Medical University and various leadership roles at companies such as AbbVie and Abbott Laboratories, Bespalov brings a wealth of knowledge and expertise in pharmacology to their current positions. A Doctor of Medical Sciences, Bespalov has a strong educational background in medicine and pharmacology.
This person is not in any teams
EXCIVA GmbH
exciva is a Provider of targeted drug rescue program intended to involve pharmaceutical research and development based in Heidelberg, Germany. The company's program has been formulated for developing symptomatic and disease-modifying treatments, therapies, cures, prophylactics, supplements, formulations and methods of making and using suchcompositions, enabling the healthcare industry to access their program for rescuing and reusing approved drugs for new indications and new uses.